Cargando…

Single-arm, phase II study of intra-arterial chemotherapy plus total neoadjuvant therapy to optimise complete response in distal rectal cancer: a study protocol

INTRODUCTION: Organ preservation is now considered an acceptable alternative option in distal rectal cancer patients with clinical complete response (cCR) after neoadjuvant chemoradiation (CRT). But the cCR rate is low and about one-third of tumour will regrow, which requires more effective local tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wenpeng, Huang, Puda, Guo, Houji, Huang, Zanyi, Wei, Mingwei, Guo, Junyu, Lin, Cheng, Li, Yepeng, Luo, Biao, Lin, Jie, Wang, Lixue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565178/ https://www.ncbi.nlm.nih.gov/pubmed/37798027 http://dx.doi.org/10.1136/bmjopen-2023-075023

Ejemplares similares

SNHG17 Serves as an Oncogenic lncRNA by Regulating the miR-361-3p/STC2 Axis in Rectal Cancer
por: Huang, Fuda, et al.
Publicado: (2021)

Measurement of distal intramural spread and the optimal distal resection by naked eyes after neoadjuvant radiation for rectal cancers
por: Sun, Ge, et al.
Publicado: (2022)

Multiphase and multiparameter MRI-based radiomics for prediction of tumor response to neoadjuvant therapy in locally advanced rectal cancer
por: Huang, Hongyan, et al.
Publicado: (2023)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Song, Seung Ho, et al.
Publicado: (2021)

miR-654-5p Targets HAX-1 to Regulate the Malignancy Behaviors of Colorectal Cancer Cells
por: Huang, Fuda, et al.
Publicado: (2020)

Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2020)

Livin serves as a prognostic marker for mid-distal rectal cancer and a target of mid-distal rectal cancer treatment
por: Su, Qi-Biao, et al.
Publicado: (2017)

Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial
por: Deng, Xiangbing, et al.
Publicado: (2021)

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
por: Wu, Jingjing, et al.
Publicado: (2023)

Optimising functional outcomes in rectal cancer surgery
por: Nocera, Fabio, et al.
Publicado: (2020)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy
por: Sorrentino, Luca, et al.
Publicado: (2023)

Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
por: Song, Jianyuan, et al.
Publicado: (2020)

Effect of Neoadjuvant Chemoradiotherapy on Locally Advanced Rectal Mucinous Adenocarcinoma: A Propensity Score-Matched Study
por: Sun, Yan-wu, et al.
Publicado: (2017)

Machine learning for predicting pathological complete response in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2020)

Monitoring neoadjuvant therapy responses in rectal cancer using multimodal nonlinear optical microscopy
por: Li, Lian-Huang, et al.
Publicado: (2017)

Data on patterns of initial recurrence after curative surgery for rectal cancer with neoadjuvant therapy
por: Zheng, Zhifang, et al.
Publicado: (2020)

Association of markers of systemic and local inflammation with prognosis of patients with rectal cancer who received neoadjuvant radiotherapy
por: Zhang, Xueqing, et al.
Publicado: (2018)

Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine Neoplasms
por: Srirajaskanthan, Rajaventhan, et al.
Publicado: (2023)

Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
por: Deng, Yanhong, et al.
Publicado: (2019)

Density and distribution of lymphocytes in pretherapeutic rectal cancer and response to neoadjuvant therapy
por: Lai, Sicong, et al.
Publicado: (2020)

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

Meat consumption and the risk of incident distal colon and rectal adenoma
por: Ferrucci, L M, et al.
Publicado: (2012)

Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer
por: Ren, Dong-Lin, et al.
Publicado: (2019)

Rectal atresia and rectal stenosis: the ARM-Net Consortium experience
por: de Beaufort, Cunera M. C., et al.
Publicado: (2023)

A nomogram predicting pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: implications for organ preservation strategies
por: Sun, Yanwu, et al.
Publicado: (2017)

A Case with Rectal Cancer Relapses After Clinical Complete Remission Following Neoadjuvant Chemoradiotherapy
por: Zhang, Ping-Bao, et al.
Publicado: (2019)

Dangers of Intra-Rectal Examination
Publicado: (1875)

Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics
por: Qin, Pengfei, et al.
Publicado: (2023)

Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
por: Yang, Jinsong, et al.
Publicado: (2023)

Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial
por: Liu, Shuang, et al.
Publicado: (2023)

Neoadjuvant Chemoradiotherapy Does Not Contribute to Worse Survival in Pathological Node-Negative Rectal Cancer
por: Huang, Yong, et al.
Publicado: (2021)

Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers
por: Ding, Yuedi, et al.
Publicado: (2020)

Neoadjuvant Treatment in Rectal Cancer: Actual Status
por: Garajová, Ingrid, et al.
Publicado: (2011)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer
por: Niu, Nan, et al.
Publicado: (2022)

Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis
por: Wang, Xiao-Jie, et al.
Publicado: (2016)

A nomogram for predicting good response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a retrospective, double-center, cohort study
por: Wang, Guancong, et al.
Publicado: (2022)

Intra-operative dosimetry of trans-rectal ultrasound guided (125)I prostate implants using C-arm fluoroscopic images
por: Ravindran, Paul B., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_en1ru8lbl2oudla3mt5dok1j77